-+ 0.00%
-+ 0.00%
-+ 0.00%

Maxim Group Downgrades Reviva Pharmaceuticals to Hold

Benzinga·04/08/2026 13:20:55
Listen to the news
Maxim Group analyst Jason McCarthy downgrades Reviva Pharmaceuticals (NASDAQ:RVPH) from Buy to Hold.